Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.06%
+0.23%
+14.86%
-3.80%
-3.18%
Most Trending
+4.06%
+0.23%
+14.86%
-3.80%
-3.18%
$BYND Beyond Meat stole the show with a jaw-dropping 146% surge as the plant-based food maker announced an expanded Walmart partnership. The company products are now rolling out to over 2,000 stores, including new value bundles and flavors. Add in $BYND’addition to a meme ETF and a MACD crossover, and it’s no wonder the stock traded a mind-boggling 1.7 billion shares. Reddit hype meets technical breakout this is meme stock mania 2.0.
$NERV Minerva Neurosciences rocketed 141% after announcing up to $200 million in new financing to fund its Phase 3 trial for Roluperidone, a potential schizophrenia treatment. The move marks a lifeline for the biotech and sets up a major FDA resubmission opportunity. With volume exploding 350x above average, $NERV became the day biotech darling and a favorite among momentum traders.
$BOF BranchOut Food surged 33% after reporting record Q3 results and cutting its debt by 92%. A $16 million annualized production run rate showed real business progress, sending traders scrambling for shares. The small float amplified every uptick, making $BOF one of the market most explosive microcaps today.
$IBIO iBio Inc. added 24% on the back of renewed analyst coverage and bullish chatter surrounding the biotech sector. With traders hunting for fresh speculative setups, $IBIO small market cap and volatility made it an attractive short-term trading vehicle. The setup looks ripe for those who thrive on biotech swings — but caution is key.
$DCGO DocGo popped 24% after announcing its acquisition of virtual care platform **SteadyMD**, expanding its reach in telehealth. The strategic move strengthened its position in a fast-evolving digital health market and reignited trader confidence.
But where there are winners, there are always losers and today red-laners tell their own story.
$AREB American Rebel Holdings plunged over 33% as the stock continued a brutal nine-day losing streak. The consistent sell pressure hints at capitulation, with no fresh catalysts in sight to revive sentiment. For now, it’s catching falling knives territory.
$MSPR MSP Recovery extended its losing streak to eight consecutive sessions, dropping nearly 19%. The company has struggled to regain investor trust amid ongoing dilution and legal uncertainty. Traders are steering clear until clarity emerges.
$CLF Cleveland-Cliffs shed 17% after a bearish analyst downgrade hit the tape. The downgrade cited weakening steel demand and margin pressure, sending industrial names lower across the board. $CLF bulls are licking their wounds as Wall Street tone turns cautious.
$CRML Critical Metals fell nearly 17% after filing to sell over 18 million shares for existing holders, sparking dilution fears. Traders hate secondary offerings, and this one hit sentiment hard, driving volume spikes as investors headed for the exits.
$WGRX Wagerr slipped 16% after falling for a fifth straight day, weighed down by persistent selling and no major catalysts to turn the tide. Momentum traders have largely abandoned the name, waiting for signs of stabilization.
Yesterday at 08:50
Yesterday at 08:38
Yesterday at 01:13
Yesterday at 01:03
Yesterday at 12:49
Yesterday at 12:11
October 20, 2025 08:36 PM
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Yesterday at 08:50
Yesterday at 08:38
Yesterday at 01:13
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.